Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-032060
Filing Date
2025-04-04
Accepted
2025-04-04 10:54:24
Documents
1
Period of Report
2025-04-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2511399-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2511399-2_4seq1.xml 4 3810
  Complete submission text file 0001104659-25-032060.txt   5560
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE BOW STREET CAMBRIDGE MA 02138
Business Address
Cherington Charles (Reporting) CIK: 0001448698 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11460 | Film No.: 25812435